DUBLIN, Feb. 24, 2022 /PRNewswire/ -- The "Aerosol Delivery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
The global aerosol delivery devices market reached a value of US$ 41.45 billion in 2021. Looking forward, the market is projected to reach a value of US$ 60.14 billion by 2027 exhibiting a CAGR of 5.70% during 2022-2027.
Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
The global outbreak of the coronavirus disease (COVID-19) that leads to acute respiratory infections among patients represents one of the key factors driving the need for aerosol delivery devices. These devices assist in treating obstructive airway diseases at home and in healthcare settings.
Apart from this, the rising prevalence of chronic respiratory infections due to surging air pollution levels, allergens and occupational risks, and the increasing number of individuals who smoke tobacco and drink is propelling the market growth. Moreover, a considerable rise in the geriatric population, which is more vulnerable to developing serious health illnesses, is positively influencing the demand for portable inhalation devices that are convenient and economical.
Besides this, market players are developing novel aerosol delivery devices that help treat chronic inflammation and infection in the lungs and improve airway clearance in patients with cystic fibrosis (CF). Furthermore, they are offering mini ultrasonic nebulizers and inhalers through e-commerce channels that have automatic memory and are easy to use while traveling. This, in confluence with the escalating demand for personalized drug therapy and the increasing use of online channels for purchasing medical supplies, is driving the market.
Key Market Segmentation
This report provides an analysis of the key trends in each sub-segment of the global aerosol delivery devices market, along with forecasts at the global, regional and country level from 2022-2027. The report has categorized the market based on product, application and distribution channel.
Breakup by Product:
- Dry Powder Inhalers
- Single Dose Inhalers
- Multi Dose Inhalers
- Metered Dose Inhalers
- Conventional Pressurized Inhalers
- Soft Mist Inhalers
- Nebulizers
- Jet Nebulizers
- Ultrasonic Wave Nebulizers
- Vibrating Mesh Nebulizers
Breakup by Application:
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Cystic Fibrosis
- Non-Respiratory Diseases
- Diabetes
- Analgesia
- Parkinson's Disease
Breakup by Distribution Channel:
- Retail Pharmacies
- Hospital Pharmacies
- Online Stores
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Competitive Landscape
The competitive landscape of the industry has also been examined along with the profiles of the key players being:
- 3M Company
- Aerogen
- GlaxoSmithKline plc
- Johnson & Johnson
- Koninklijke Philips N.V.
- Merck & Co. Inc.
- Metall Zug AG
- Recipharm AB (publ)
- Teva Pharmaceutical Industries Ltd.
- Vectura Group plc
Key Questions Answered in this Report
- How has the global aerosol delivery devices market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global aerosol delivery devices market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global aerosol delivery devices market and who are the key players?
- What is the degree of competition in the industry?
For more information about this report visit https://www.researchandmarkets.com/r/e9iai9
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article